Redcliffe Labs is offering a Prostate Health Index (PHI) test for patients across India Blood test for Prostate Health Index (PHI) helps identify patients who require prostate biopsy, reducing the occurrence of negative biopsies. Redcliffe Labs, one of India's fastest-growing omnichannel diagnostics service providers, expanded
Redcliffe Labs, a leading omnichannel Pan India diagnostics service provider, has collaborated with Abbott India, a global healthcare giant to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This groundbreaking development aims
Redcliffe Labs, a leading omnichannel Pan India diagnostics service provider, has collaborated with Abbott India, a global healthcare giant to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This groundbreaking development aims to revolutionize healthcare, offering
Nine (2.48%) women out of 362 were screen positive for chromosomopathy Ground-breaking Research on Prenatal Screening for Chromosomal Anomalies Redcliffe Labs, a leading omni-channel Pan India diagnostics service provider, has come out with an comprehensive research study on prenatal screening for chromosomal anomalies. Led by Dr. Sohini
Dr. Sohini Sengupta Medical Laboratory Director, Redcliffe Labs Although the summer is approaching and temperatures begin to rise, the flu season is still here, and many people have started experiencing symptoms of the influenza virus. This year, the H3N2 strain is one of the most prevalent types
Redcliffe Labs, a leading pan-India omnichannel diagnostic company in India, has announced the launch of the BD MAX MDR TB test, which can detect multidrug-resistant tuberculosis (MDR-TB) in a single test, enabling clinicians to quickly test for TB and multidrug resistance as a first-line test.
